Zobrazeno 31 - 40
of 103
pro vyhledávání: '"Mugen Ujiie"'
Autor:
Mugen Ujiie
Publikováno v:
Glob Health Med
Although ten vaccines against novel coronavirus infection (COVID-19) have been placed on the World Health Organization (WHO)'s emergency use list, no vaccine has been developed by Japanese pharmaceutical companies. As of March 2022, 10 billion doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a04e157d9d7414d0c6ca634127abfd8
https://europepmc.org/articles/PMC9066468/
https://europepmc.org/articles/PMC9066468/
Autor:
Tomohiro Asaoka, Jun Kuroki, Yasuyuki Kato, Toshikazu Terashima, Yasutaka Kakinoki, Mugen Ujiie, Michinori Shirano, Toshiyuki Ito
Publikováno v:
Kansenshogaku Zasshi. 95:32-36
The novel coronavirus disease 2019 (COVID-19) was first reported to the World Health Organization by the WHO country office in China in December 2019 and has since become a worldwide pandemic In Japan, COVID-19 is a designated infectious disease unde
Autor:
Seik-Soon Khor, Yosuke Omae, Junko S. Takeuchi, Ami Fukunaga, Shohei Yamamoto, Akihito Tanaka, Kouki Matsuda, Moto Kimura, Kenji Maeda, Gohzoh Ueda, Tetsuya Mizoue, Mugen Ujiie, Hiroaki Mitsuya, Norio Ohmagari, Wataru Sugiura, Katsushi Tokunaga
BNT162b2, an mRNA-based SARS-CoV-2 vaccine (Pfizer-BioNTech), is one of the most effective COVID-19 vaccines and has been approved by more than 130 countries worldwide. However, several studies have reported that the COVID-19 vaccine shows high inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b45dce30bda6cb8080ec5802dbdad81
https://doi.org/10.1101/2022.02.01.22270285
https://doi.org/10.1101/2022.02.01.22270285
Autor:
Tetsuya Suzuki, Noriko Iwamoto, Shinya Tsuzuki, Yuko Kakumoto, Michiyo Suzuki, Shinobu Ashida, Yusuke Oshiro, Takeshi Nemoto, Kohei Kanda, Ayako Okuhama, Gen Yamada, Makoto Inada, Lubna Sato, Yusuke Miyazato, Yutaro Akiyama, Sho Saito, Shinichiro Morioka, Mugen Ujiie, Kayoko Hayakawa, Masaya Sugiyama, Masashi Mizokami, Eiichi N. Kodama, Norio Ohmagari
Publikováno v:
European journal of clinical investigation
Autor:
Nobumasa Okumura, Shinya Tsuzuki, Sho Saito, Shin-ichiro Hattori, Junko S. Takeuchi, Tomoya Saito, Mugen Ujiie, Masayuki Hojo, Noriko Iwamoto, Wataru Sugiura, Hiroaki Mitsuya, Norio Ohmagari
Publikováno v:
Journal of infection and chemotherapy
Journal of Infection and Chemotherapy
Journal of Infection and Chemotherapy
The Omicron variant of severe acute respiratory syndrome coronavirus 2 has multiple amino acid mutations in its spike proteins, which may allow it to evade immunity elicited by vaccination. We examined the neutralising activity and S1-IgG titres in p
Autor:
Norio Ohmagari, Kei Yamamoto, Satoshi Ide, Haruhito Sugiyama, Tetsuya Suzuki, Shinichiro Morioka, Yuki Moriyama, Yuji Wakimoto, Yusuke Miyazato, Yutaro Akiyama, Masayuki Hojo, Tetsuya Mizoue, Sho Saito, Masahiro Ishikane, Takato Nakamoto, Kayoko Hayakawa, Keiji Nakamura, Jin Takasaki, Satoshi Kutsuna, Noriko Kinoshita, Mugen Ujiie, Hidetoshi Nomoto, Masayuki Ota, Yusuke Asai, Mari Terada
Publikováno v:
Glob Health Med
Since the initial report of coronavirus disease (COVID-19) from the City of Wuhan, China in December 2019, there have been multiple cases globally. Reported here are 11 cases of COVID-19 at this hospital; all of the patients in question presented wit
Autor:
Gohzoh Ueda, Mugen Ujiie, Akihito Tanaka, Hiroaki Mitsuya, Norio Ohmagari, Tetsuya Mizoue, Junko S Takeuchi, Yumiko Kito, Moto Kimura, Shohei Yamamoto, Kouki Matsuda, Ami Fukunaga, Azusa Kamikawa, Wataru Sugiura, Kenji Maeda
IntroductionThe humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) upon coronavirus disease 2019 (COVID-19) vaccination remain to be clarified. Hence, we aimed to investigate the long-term chron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3c7c3c7f2884c1325587afad504d313
https://doi.org/10.1101/2021.11.06.21265632
https://doi.org/10.1101/2021.11.06.21265632
Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease
Autor:
Keiji Nakamura, Masayuki Hojo, Satoshi Ide, Shinyu Izumi, Yumi Funato, Shinichiro Morioka, Takato Nakamoto, Mugen Ujiie, Masahiro Ishikane, Akira Kawashima, Katsuji Teruya, Makoto Inada, Sho Saito, Lubna Sato, Yoshitaka Shida, Norio Ohmagari, Tetsuya Suzuki, Gen Yamada, Yusuke Miyazato, Ayako Okuhama, Masatoshi Hotta, Mari Terada, Tsuyoshi Tajima, Hidetoshi Nomoto, Kohei Kanda, Makiko Yamamoto, Mitsuhiro Sato, Noriko Kinoshita, Yutaro Akiyama, Satoshi Kustuna, Kei Yamamoto, Haruhito Sugiyama, Kayoko Hayakawa
Publikováno v:
Journal of Infection and Chemotherapy
Objectives To alleviate the overflow of coronavirus disease 2019 (COVID-19) patients in hospitals, less invasive and simple criteria are required to triage the patients. We evaluated the relationship between COVID-19 severity and fatty liver on plain
Autor:
Mugen Ujiie, Shinichiro Morioka, Keiko Tanaka, Tomomi Hamano, Yasuyo Osanai, Kei Yamamoto, Sho Saito, Masahiro Isikane, Satoshi Kutsuna, Norio Ohmagari, Noriko Kinoshita, Yasuo Sugiura, Kayoko Hayakawa
Publikováno v:
Glob Health Med
Once novel coronavirus disease 2019 (COVID-19) emerged in Wuhan, China in December 2019 and the first case in Japan was reported the following month, telephone inquiries to the Infectious Disease Outpatient Clinic increased. During the first wave of
Autor:
Tetsuya Suzuki, Shinji Izuka, Saho Takaya, Noriko Kinoshita, Kota Yamada, Toshiaki Kobayashi, Maho Taguchi, Yusuke Miyazato, Ayako Okuhama, Erika Sugito, Yuki Moriyama, Satoshi Ide, Yuji Wakimoto, Takato Nakamoto, Shuji Kubota, Keiji Nakamura, Hidetoshi Nomoto, Kenji Ishiguro, Kohei Kanda, Shinichiro Morioka, Masayuki Ota, Wataru Miyake, Kei Yamamoto, Masahiro Ishikane, Norio Ohmagari, Akira Kawashima, Mugen Ujiie, Sho Saito, Yutaro Akiyama, Kayoko Hayakawa, Satoshi Kutsuna
Publikováno v:
Internal Medicine
Objective In fever clinics screening coronavirus disease (COVID-19), there could be patients with life-threatening diseases that physicians should not overlook. We exploratorily investigated the final diagnosis among non-COVID-19 hospitalized patient